Some research has suggested that consumption of high-fructose corn syrup, used as a sweetener in a wide variety of foods, may increase the risk of obesity and heart disease. Now, a controlled and randomized study has found that drinks sweetened with fructose led to higher blood levels of L.D.L, or "bad" cholesterol, and triglycerides in overweight test subjects, while drinks sweetened with another sugar, glucose, did not.
Living near power lines may significantly increase a person’s risk of death from Alzheimer’s disease or senile dementia.
Researchers from the University of Bern, Switzerland, have found that people who lived within 50 metres of a long-distance power transmission line were 1.24 times more likely to die of Alzheimer’s disease than those who lived 600 metres or more away.
Those who had lived near the power line for five years or more had 1.51 times the risk of those living farther away. This risk was increased 1.71 times for those who had lived close to a power line for 10 years, and two times for those who had lived within 50 meters for 15 years or more.
Exposure to chemicals used in plastics may be linked with childhood obesity, according to results from a long-term health study on girls who live in East Harlem and surrounding communities that were presented to community leaders on Thursday by researchers at Mount Sinai Medical Center.
The chemicals in question are called phthalates, which are used to to make plastics pliable and in personal care products. Phthalates, which are absorbed into the body, are a type of endocrine disruptor — chemicals that affect glands and hormones that regulate many bodily functions. They have raised concerns as possible carcinogens for more than a decade, but attention over their role in obesity is relatively recent.
Chuck Stauffer’s insurance covered the surgery to remove his brain tumor. It covered his brain scans. And it would have paid fully for tens of thousands of dollars of intravenous chemotherapy at a doctor’s office or hospital.
But his insurance covered hardly any of the cost of the cancer pills the doctor prescribed for him to take at home. Mr. Stauffer, a 62-year-old Oregon farmer, had to pay $5,500 for the first 42-day supply of the drug, Temodar, and $1,700 a month after that.
The Environmental Appeals Board of the U.S. federal government has granted the DuPont corporation a three-year extension on its obligation to conduct a comprehensive assessment of a widely used chemical believed to expose consumers to the toxic substance perfluorooctanoic acid (PFOA).
A new drug halts the devastating progress of Alzheimer’s disease, say British scientists.
It is said to be more than twice as effective as current treatments.
A daily capsule of rember, as the drug is known, stops Alzheimer’s disease progressing by as much as 81 per cent, according to trial results.
Page 178 of 217